Athos Capital’s SpringWorks Therapeutics SWTX Stock Holding History

Athos Capital’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,000	Closed	-$2.35M	–	43
2025 Q2	$2.35M	Buy	+50,000	New	+$2.22M	3.51%	16

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Athos Capital's SWTX Position: Q3 2025 in Review

Athos Capital sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 50,000 shares — an estimated $2.35M sold.

Athos Capital first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $2.35M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Athos Capital reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Athos Capital sold 50,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.35M.
Athos Capital first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Athos Capital's SpringWorks Therapeutics position peaked at $2.35M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Athos Capital's 13F filing for Q3 2025, filed 13 Nov 2025.